Merit Medical acquires Biolife Delaware for $120M

Merit Medical Systems acquired Biolife Delaware, a manufacturer of hemostatic devices, for approximately $120 million in cash and assumed liabilities. The acquisition adds the StatSeal and WoundSeal product lines to Merit's portfolio.

“We are excited to enhance the portfolio of hemostatic solutions offered to clinicians with the acquisition of Biolife.”barchart.com

• 3 sources
• barchart.comMerit Medical Acquires Biolife Delaware, L.L.C.Merit Medical Systems, Inc.May 20, 2025
• mddionline.comMerit Medical 'Seals' Biolife Delaware AcquisitionAmanda PedersenMay 20, 2025
• interventionalnews.comMerit Medical acquires haemostatic device manufacturer Biolife - Interventional NewsÉva MalpassMay 21, 2025

Summarized from public sources; check the original articles before acting on it.